Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Conditions:   Infertility, Female;   Infertility;   Genital Diseases, Male;   Genital Diseases, Female;   Progesterone;   Dydrogesterone;   Hormones;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Physiological Effects of Drugs;   Progestins
Interventions:   Drug: Dydrogesterone Oral Tablet;   Drug: Micronized progesterone;   Drug: Placebo Dydrogesterone oral tablet;   Drug: Placebo Micronized progesterone
Sponsors:   CRG UZ Brussel;   Universitätsklinikum Hamburg-Eppendorf;   Abbott;   KU Leuven
Not yet recruiting

https://ift.tt/2NqBdXy